{
  "ticker": "NVO",
  "name": "Novo Nordisk A/S",
  "price": 50.37,
  "market_cap": 223818055680,
  "revenue_ttm": 49640674767.01663,
  "net_income_ttm": 16322283826.825527,
  "ocf_ttm": 19469780975.974205,
  "capex_ttm": 9883056112.618458,
  "sbc_ttm": 0.0,
  "buyback_ttm": 1396563249.5772874,
  "total_debt": 15919782942.078566,
  "cash_and_equivalents": 5124926271.086469,
  "book_value_ttm": 26722661318.862804,
  "shares_outstanding": 3368607341,
  "beta": 1.2,
  "roe": 71.47,
  "analyst_growth_estimate": 5.1,
  "forward_eps": 3.4660072,
  "dividend_yield": 344.0,
  "sector_type": "BioTech",
  "currency_code": "USD",
  "last_updated": "2025-12-16T01:27:33Z"
}